Thomas J. Long School of Pharmacy and Health Sciences
Industrial Advisory Board
The program is closely aligned with industrial interests and guided by an external advisory board consisting of scientists, managers, practitioners and Pacific alumni from pharmaceutical, biotechnical and chemical companies as well as research institutes and other universities.
A few of the dynamic companies and executives involved in the program include:
| Name | Title | Company |
|---|---|---|
| John Barr | Vice President, Research and Development | A.P. Pharma, Inc. |
| David Bennett | Senior Director, Pharmaceutical Sciences | Neurogesx, Inc. |
| Bret Berner | Consultant | |
| Terry Burkoth | CEO | Paceline Consulting |
| Bhaskar Chaudhuri | President and CEO | Dow Pharmaceutical Sciences |
| Gary Cleary | President and CTO | Corium Technology Group |
| Jeffrey Cleland | Vice President, Therapeutic Development | Barofold, Inc. |
| Kenneth Fong | Chairman | Kenson Ventures, LLC |
| John Hearst | Professor Emeritus, UC Berkeley; Founder and Consultant | Cerus Corporation |
| Brian Johnston | President and CEO | Somagenics, Inc. |
| Norm Kobayashi | Vice President, Quality Assurance and Regulatory Compliance | Delta Project Management, LLC |
| David Lauper | Otsuka America Pharmaceutical | |
| Robert A. Reed | Vice President, Pharmaceutical Operations | XenoPort, Inc. |
| Sam Rose | Scientific Affairs | Roche Molecular Systems, Inc. |
| Satyam Upadrashta | Senior Director, Regulatory Affairs and Quality Control | Aradigm Corporation |
| Guo-Liang Yu | Chairman, President and CEO | Epitomics, Inc. |
